A Multi-Center, Randomized, Double-Blind, Placebo Controlled Phase 3 Safety and Effectiveness Trial of a Vaginal Matrix Ring With Dapivirine for the Prevention of HIV-1 Infection in Women

Trial Profile

A Multi-Center, Randomized, Double-Blind, Placebo Controlled Phase 3 Safety and Effectiveness Trial of a Vaginal Matrix Ring With Dapivirine for the Prevention of HIV-1 Infection in Women

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Sep 2017

At a glance

  • Drugs Dapivirine (Primary)
  • Indications HIV infections
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jun 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
    • 27 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Dec 2010 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top